Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers

NCT05125575 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
DRUG: Glucophage® XR 1000 mg Prolonged Release Tablets

Sponsor

Joint Stock Company "Farmak"